2-Fluoro-N-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline

Catalog No. :
ACEPOA895
CAS No. :
1428329-75-2
Molecular Formula :
C13H19BFNO2
Molecular Weight :
251.11

IUPAC Name:2-fluoro-N-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline

2-Fluoro-N-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$140.00Login to see priceIn stockInquiry
250mg95%$223.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Fluoro-N-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
IUPAC Name2-fluoro-N-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
Molecular FormulaC13H19BFNO2
Molecular Weight251.11
SMILESCC1(C)C(C)(C)OB(C2=CC(F)=C(NC)C=C2)O1
InChI KeyJVGMPYIVZLFBDZ-UHFFFAOYSA-N
Synonym2-fluoro-N-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenamine;Benzenamine, 2-fluoro-N-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;2-Fluoro-N-methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)aniline;2-Fluoro-N-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
CAS No.1428329-75-2

Synthetic Route by SureRoute

1. ACEPOA895 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACFYSN091 route compound structure diagram
    ACFYSN0911197930-28-1 In Stock
  4. Then
  5. ACEPOA895 route product structure diagram
    ACEPOA8951428329-75-2 In Stock
Inquiry

2. ACEPOA895 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGTNV280 route compound structure diagram
    ACGTNV280819058-34-9 In Stock
  4. Then
  5. ACEPOA895 route product structure diagram
    ACEPOA8951428329-75-2 In Stock
Inquiry

Comments (0)